Use of the Quantra QPlus Sytem in Cardiac Surgery

Single center retrospective study evaluating the impact of using the Quantra QPlus System to guide transfusion decisions on postoperative outcomes in patients undergoing cardiac surgery.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cardiovascular Diseases Embolism and Thrombosis Thrombosis Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Yavapai Regional Medical Center

Prescott, Arizona, 86301, United States

About this study

Yavapai Regional Medical Center (YRMC) implemented the Quantra QPlus System to aid in their efforts to effectively reduce the transfusion rate of allogenic blood products and improve outcomes in patients undergoing cardiac surgery. Use of the Quantra to guide decisions related to the use of blood products in cardiac surgery patients began in 2019. In this retrospective study, YRMC evaluated the impact of using the Quantra QPlus System to guide transfusion decisions on postoperative outcomes in patients undergoing cardiac surgery.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Pre-Quantra Group: All consecutive patients undergoing cardiac surgical procedures during the period from January 2019 to September 2019 (n=64)
Post-Quantra Group: All consecutive patients undergoing cardiac surgical procedures during the period from May 2020 to April 2021 (n=64)

Treatment and study plan

Quantra QPlus System

Diagnostic Test

Coagulation monitoring system

Primary outcomes

Blood product utilization

Time frame: Intraoperative - during surgery

Units of blood products administered to patient
Blood product utilization

Time frame: Postoperative - after surgery throughout the rest of the hospital stay, assessed up to 30 days

Units of blood products administered to patient
Cost of blood products

Time frame: Throughout the entire hospital stay, assessed up to 30 days

Total cost of blood products administered to patient

Sponsors and collaborators

Lead sponsor

HemoSonics LLC

Industry

Registry information

Official study title

Utilization of the Quantra QPlus System to Guide the Management of Blood Product Transfusions in Cardiac Surgery Patients: Effects on Clinical and Economic Outcomes

Important dates

Study start: 2021
Primary completion: 2021
Study completion: 2021
First posted: Aug 15, 2022
Registry last updated: Aug 15, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed